Drug List

CN EN

Stock code: 002653.SZ

Home

News

Innovation

Pipeline R&D Platforms

Products

Product List Product Topics Pharmacovigilance

Investors

Stock Information Company Announcements Market Data Q&A Investor Hotline

Join Us

Talent Philosophy Careers

About Haisco

About Us Business Presence

GLOBAL

English China

Committed to Becoming the Most Trusted International Pharmaceutical Company

Innovation and quality guide everything we do at Haisco. Our core products protect health and bring the reliability of Chinese-developed medicines to patients worldwide.

Anesthesia/Pain Relief

SISHUNING® (Cinophorol Injection)

China's first independently developed Class 1 intravenous anesthetic with global independent intellectual property rights

Learn more

Endocrine System

BEICHANGPING® (Cofrogliptin Tablets)

BEICHANGPING® (Cofrogliptin Tablets) is the world's first ultra-long-acting oral diabetes medicine taken once every two weeks.

Learn more

SIMEINING® (Crisabalin Besilate Capsules)

Neurological and Psychiatric System

SIMEINING® (Crisabalin Besilate Capsules)

The world's first third-generation calcium channel modulator that requires no titration

Learn more

Anesthesia and Analgesia

SISHUJING® (Anrikefon Injection)

The first highly selective peripheral K receptor agonist with analgesic indications in the world.

Learn more

SIFU® (Polyene Phosphatidylcholine Injection)

Digestive and Hepatic Diseases

SIFU® (Polyene Phosphatidylcholine Injection)

China's only injectable therapy for hepatocyte membrane repair and Haisco's exclusive first-to-market generic

Learn more

Oncology

LIBIFU® (Dolasetron Mesylate)

For the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin

Learn more

YOUKEPAN® (Ciprocopan Succinate Tablets)

Autoimmune Disease

YOUKEPAN® (Ciprocopan Succinate Tablets)

Ciprocopan Succinate Tablets are the world's first once-daily oral first-line therapy for PNH.

Learn more

/07

Quality Medicines for Better Health

Haisco Pharmaceutical Group focuses on five major therapeutic areas: Anesthesia and Analgesia, Chronic Metabolic Diseases, Respiratory Disease, Autoimmune Disease, and Oncology. The Group markets more than 46 drugs, including four Class 1 innovative drugs covered by China's national medical insurance program.

Anesthesia and Analgesia Endocrine System Enteral and Parenteral Nutrition Neurological and Psychiatric System Cardiovascular System Oncology Digestive and Hepatic Diseases Andrology Others

SISHUNING ® (Cipepofol Injection)

Intravenous anesthetic

Package Insert

SISHUJING ® (Anrikefon Injection)

Opioid analgesic

Package Insert